On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
Please provide your email address to receive an email when new articles are posted on . The approval applies to certain patients with myasthenia gravis or chronic inflammatory demyelinating ...
Growing numbers of people are injecting unregulated peptides for health reasons - but one expert says they are "lab rats".
Hosted on MSN
How to Inject Yourself With GLP-1 Medications
It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with glucagon-like peptide 1 agonists (GLP-1s). The thought of self-injection often causes ...
For people who have survived a heart attack, the notion of one shot in the arm to help the heart heal, for weeks after, may seem far-fetched. But thanks to a team of researchers, including a Texas A&M ...
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
The CDC reported that three individuals were hospitalized with botulism-type symptoms in May and June following self-injection of botulinum toxin they purchased online for cosmetic use. The case ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results